Will BioNtech sustain the $140 support level?
BioNtech SE (NASDAQ: BNTX) is bullish this week, having gained 16.03% to trade at $158. The gains come after the company reported growth in vaccine sales. The company still expects vaccine sales to decline. This week’s rally comes after the company announced the completion of Phase II coronavirus vaccine trials in China. BioNtech is a
The post Will BioNtech sustain the $140 support level? appeared first on Invezz.